Stock screener

BHC

Conviction 40HealthcareScan · Thu, Sep 24, 2026

Bausch Health Companies Inc. (BHC) closed at $5.65 (-1.05%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 40, RS Rating 38, -28.5% from its 52-week high, -21.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

BHC$5.65-1.05%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.2M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Bausch Health Companies Inc.PHARMACEUTICAL PREPARATIONSwww.bauschhealth.com ↗
Price5.65
Change-1.05%
Gap+0.79%
Rel volume1.44×
Avg volume2.5M
Avg $ vol15.4M
SMA 206.08
SMA 505.95
SMA 2005.81
Price vs 50-5.09%
Price vs 200-2.78%
MA stackmixed
50/200 crossgolden · 6d
Supertrenddown · 6.41
RSI (14)40
MACD hist-0.07
MACD cross—
Stoch %K / %D9 / 13
ADX (14)21
+DI / −DI19 / 25
RSI divergence—
MACD divergence—
ATR %4.66%
ADR %3.99%
52w high7.90
52w low4.43
From 52w high-28.48%
Above 52w low+27.54%
New 52w highNo
SqueezeOff
Bollinger width25.75%
%B0.23
Donchian pos7.27%
Donchian high6.99
Donchian low5.55
AVWAP (52w high)5.80
vs AVWAP high-2.62%
AVWAP (52w low)6.20
vs AVWAP low-8.85%
OBV trendFlat
Chaikin MF (20)-0.11
Today vs 20d1.44×
Avg vol (14d)2.2M
Avg vol (20d)2.5M
Avg $ vol (20d)15.4M
Market cap2.11B
RS Rating38 / 99
RS 3m (vs SPY)+2.52%
RS 6m (vs SPY)-5.60%
RS line new highNo
Trend template1/8
Technical rank44.5
1 week+0.00%
1 month-16.05%
3 months+7.01%
6 months+11.22%
1 year-15.80%
YTD-21.64%
P/E13.46
P/B-1.19
P/S0.21
P/FCF2.11
EPS0.4200
Div yield16.86%
ROE-8.87%
ROA0.63%
Debt/Eq-11.71
Current1.44
EV/EBITDA6.96
Gross margin—
Net margin1.53%
Rev growth6.66%
EPS growth441.30%
Price target9.00
Target upside59.29%
Analyst ratingHold
Institutional66.62%
Ent. value21.03B
Revenue2.85B
Net income258M
Gross profit—
Free cash flow1B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out374.02M
Employees20.3K
ListedThu, Mar 31, 1994
Free float262.07M
Float %70.3%
Short interest8.22M
Days to cover3.0d
Short volume39.6%
Squeeze score28 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.26 vs $0.96
Last surprise+31.3% beat
Setup gradeD
Conviction40 / 100
Pattern quality—
Tech rank44.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.19
Support5.72
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BHC

All disclosures →
No recent disclosed trades by Congress in BHC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BHC · open-market 1 sell

InsiderSideShares
Lenar Aimee J.
President, US Pharma · Common Shares, No Par Value · 2026-08-19
Sell36.83K
Lenar Aimee J.
President, US Pharma · Common Shares, No Par Value · 2026-07-15
Tax23.39K
LEE STEVEN HYOSIG
SVP, Controller & CAO · Common Shares, No Par Value · 2026-07-14
Tax3.13K
LEUNG SANDRA
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Garcia Christian A
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
ROBERTS EIRY
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Lee Frank D.
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
WECHSLER AMY B
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Paulson John
Director · Common Shares, No Par Value · 2026-05-22
Other—
POWER ROBERT N
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K

SEC filings

EDGAR filings in BHC · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.